N-Methyl-N-isopropyl-butyramid | 54966-01-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: N-Methyl-N-isopropyl-butyramid
• 英文别名: Butanamide, N-methyl-N-(1-methylethyl)-；N-methyl-N-propan-2-ylbutanamide
• CAS: 54966-01-7
• 化学式: C₈H₁₇NO
• 分子量: 143.229
• InChiKey: LUCPPJKVMUVRBR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-Methyl-N-isopropyl-butyramid 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 生成 N-methyl-N-isopropyl-N-butylamine
  参考文献：
  名称：

  Mass Spectrometry in Structural and Stereochemical Problems. LXXXV.¹ The Nature of the Cyclic Transition State in Hydrogen Rearrangements of Aliphatic Amines^2,3

  摘要：

  DOI：

  10.1021/ja00952a040
• 作为产物：
  描述：

  N-异丙基甲胺 、 丁酰氯 以 乙醚 为溶剂， 生成 N-Methyl-N-isopropyl-butyramid
  参考文献：
  名称：

  Mass Spectrometry in Structural and Stereochemical Problems. LXXXV.¹ The Nature of the Cyclic Transition State in Hydrogen Rearrangements of Aliphatic Amines^2,3

  摘要：

  DOI：

  10.1021/ja00952a040

文献信息

• Modulators of muscarinic receptors
  申请人：Makings R. Lewis

  公开号：US20080015179A1

  公开（公告）日：2008-01-17

  The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.

  本发明涉及肌胆碱受体调节剂。本发明还提供包含这种调节剂的组合物，并提供了用于治疗肌胆碱受体介导疾病的方法。
• 5-Phenyl-4-Methyl-Thiazol-2-Yl-Amine Derivatives as Inhibitors of Phosphatidylin Ositol 3 Kinase Enzymes (PI13) For Treatment of Inflammatory Diseases
  申请人：Bloomfield Graham Charles

  公开号：US20080280871A1

  公开（公告）日：2008-11-13

  in free or salt form, wherein R a , R b , R 2 , R 3 , R 4 and R 5 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.

  在自由或盐形式中，其中Ra，Rb，R2，R3，R4和R5具有规范中指示的含义，对于治疗由磷脂酰肌醇3-激酶介导的疾病是有用的。还描述了含有该化合物的药物组合物以及制备该化合物的过程。
• 5-PHENYL-4-METHYL-THIAZOL-2-YL-AMINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3 KINASE ENZYMES (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES
  申请人：Bloomfield Graham Charles

  公开号：US20110124624A1

  公开（公告）日：2011-05-26

  Compounds of Formula I: in free or salt form, wherein R a , R b , R 2 , R 3 , R 4 and R 5 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.

  公式I的化合物：以自由或盐形式存在，其中Ra、Rb、R2、R3、R4和R5的含义如规范中所示，可用于治疗由磷脂酰肌醇3-激酶介导的疾病。还描述了含有这些化合物的制药组合物和制备这些化合物的过程。
• METHODS AND COMPOSITIONS FOR USE IN OIL AND/OR GAS WELLS COMPRISING A TERPENE ALCOHOL
  申请人：Flotek Chemistry, LLC

  公开号：EP3144366A1

  公开（公告）日：2017-03-22

  Methods and compositions comprising an emulsion or a microemulsion for use in various aspects of the life cycle of an oil and/or gas well are provided. In some embodiments, the emulsion or the microemulsion comprises an aqueous phase, a nonaqueous phase comprising a terpene alcohol a non-oxygenated terpene, and a surfactant, and optionally, one or more additives.

  本文提供了包含乳液或微乳液的方法和组合物，可用于油井和/或气井生命周期的各个方面。在某些实施方案中，乳液或微乳液包括水相、由萜烯醇、非氧萜烯和表面活性剂组成的非水相及一种或多种添加剂。
• Methods and compositions for use in oil and/or gas wells
  申请人：Flotek Chemistry, LLC

  公开号：US10000693B2

  公开（公告）日：2018-06-19

  Methods and compositions comprising an emulsion or a microemulsion for use in various aspects of the life cycle of an oil and/or gas well are provided. In some embodiments, the emulsion or the microemulsion comprises water, a solvent, and a surfactant, and optionally, one or more additives.

  本文提供了包含乳液或微乳液的方法和组合物，用于油井和/或气井生命周期的各个方面。在某些实施方案中，乳液或微乳液包括水、溶剂和表面活性剂，以及可选的一种或多种添加剂。